Dupilumab Improves Sense of Smell and Reduces Anosmia Among Patients with Nasal Polyposis and Chronic Sinusitis: Results from a Phase 2a Trial

Dupilumab Improves Sense of Smell and Reduces Anosmia Among Patients with Nasal Polyposis and Chronic Sinusitis: Results from a Phase 2a Trial

Rationale Loss of smell is a major consequence for chronic sinusitis patients with nasal polyps and is a severity marker with significant impact on quality of life.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of allergy and clinical immunology 2017-02, Vol.139 (2), p.AB90-AB90
Hauptverfasser: Naclerio, Robert M., MD, FAAAAI, Hamilos, Daniel L., MD, FAAAAI, Ferguson, Berrylin J., MD, Bachert, Claus, MD, PhD, Hellings, Peter W., MD, PhD, Mullol, Joaquim, MD, PhD, FAAAAI, Gevaert, Philippe, MD, Zhang, Donghui, Khan, Asif, Fan, Chunpeng, Joish, Vijay N, Amin, Nikhil, Pirozzi, Gianluca, Graham, Neil MH, Staudinger, Heribert W., MD, Grabher, Annette, Mannent, Leda
Format: Artikel
Sprache:eng
Schlagworte:
Allergies
Allergy and Immunology
Nose
Patient assessment
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Rationale Loss of smell is a major consequence for chronic sinusitis patients with nasal polyps and is a severity marker with significant impact on quality of life.
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2016.12.245